Curative Biotechnology Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Curative Biotechnology Inc
NIH’s National Cancer Institute licensed two experimental cancer therapies in the past month to biopharma firms, leading a heavy slate of cancer-focused tech transfer deal-making.
- Medical Devices
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Connectyx Technologies Holdings Group, Inc